Please use this identifier to cite or link to this item: http://dspace.iitrpr.ac.in:8080/xmlui/handle/123456789/2880
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMandal, P.-
dc.contributor.authorMalviya, N.-
dc.contributor.authorGuedes da Silva, M. F. C.-
dc.contributor.authorDhankhar, S. S.-
dc.contributor.authorNagaraja, C. M.-
dc.contributor.authorMobin, S. M.-
dc.contributor.authorMukhopadhyay, S.-
dc.date.accessioned2021-10-04T10:44:06Z-
dc.date.available2021-10-04T10:44:06Z-
dc.date.issued2021-10-04-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/2880-
dc.description.abstractFour new ruthenium arene PTA type complexes have been synthesized using substituted picolinamide derivatives as ancillary ligands and characterized by spectroscopic methods. In one of the complexes, the ancillary ligand has shown an unprecedented valence-bond tautomerization in the presence of an ammonium salt to act as a polar neutral donor ligand making the ligand more prone towards substitution. The same compound has shown remarkable antiproliferative activity against three cancer cell lines with GI50 values comparable to Adriamycin, a known therapeutic drug. Along with this it also strongly inhibits the action of thioredoxin reductase, which might be a probable reason for the enhanced proliferative action of the valence-bond tautomerized compound.en_US
dc.language.isoen_USen_US
dc.titleFine tuning through valence bond tautomerization of ancillary ligands in ruthenium(ii) arene complexes for better anticancer activity and enzyme inhibition propertiesen_US
dc.typeArticleen_US
Appears in Collections:Year-2016

Files in This Item:
File Description SizeFormat 
Full Text.pdf2.39 MBAdobe PDFView/Open    Request a copy


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.